doi: 10.1161/hq1201.100257
© 2001 American Heart Association, Inc.
Atherosclerosis and Lipoproteins |
Association of Multiple Risk Factors and Insulin Resistance With Increased Prevalence of Asymptomatic Coronary Artery Disease by an Electron-Beam Computed Tomographic Study
From the Department of Preventive Cardiology, St. Francis Hospital, Roslyn, New York.
Correspondence to Yadon Arad, MD, Director of Preventive Cardiology, St. Francis Hospital, 100 Port Washington Blvd, Roslyn, NY 11576. E-mail yadon{at}earthlink.net
 |
Abstract |
|---|
 Top Abstract IntroductionMethodsResultsDiscussionReferences |
|---|
The insulin resistance syndrome, consisting of resistance to insulin and several metabolic abnormalities, is associated with an increased risk of symptomatic coronary artery disease. Asymptomatic persons with increased coronary calcification have increased coronary plaque and an increased likelihood of future cardiovascular events. Electron-beam computed tomography–derived coronary artery calcium scores, metabolic and anthropometric parameters, and fasting and stimulated concentrations of glucose and insulin were measured in 1160 asymptomatic men and women. Coronary artery calcium scores were positively correlated with glucose, insulin, and homeostasis model assessment (HOMA) insulin resistance. Calcium scores were positively correlated with intra-abdominal adiposity, age, total cholesterol/high density lipoprotein (HDL) ratio, low density lipoprotein, triglycerides, blood pressure, and HOMA beta cell function and inversely correlated with HDL and peripheral fat. These correlations, except for 2-hour glucose, remained significant for all subjects with fasting serum glucose <126 mg/dL or all subjects with fasting serum glucose 110 mg/dL. In a multivariate analysis, age, sex, family history of premature coronary artery disease, intra-abdominal adiposity, low density lipoprotein, and smoking independently predicted calcium scores. Blood pressure, HDL, triglycerides, glucose, insulin, and HOMA insulin resistance or beta cell function were not independently correlated with coronary artery calcium scores. Asymptomatic individuals with insulin resistance have elevated coronary calcium scores. The association between insulin resistance and coronary calcification persists with impaired glucose tolerance and normal fasting serum glucose. Central/visceral adiposity may be a determinant of insulin resistance and atherosclerosis even in asymptomatic nondiabetic persons.
Key Words: calcium • electron-beam computed tomography • risk factors • insulin • glucose
|
Introduction |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
Type II diabetes mellitus and impaired glucose tolerance are associated with an increased risk of coronary and peripheral vascular atherosclerosis,1–7 and this association persists even in persons with glucose and hemoglobin A1C concentrations at the upper limit of the normal range.8 Insulin resistance, defined as peripheral resistance to the actions of insulin and characterized by a combination of elevated insulin and glucose concentrations, is associated with a constellation of abnormalities, including hypertension,9,10 intra-abdominal ("central" or "visceral") adiposity,11,12 and lipid abnormalities, in particular, elevated triglycerides, reduced HDL cholesterol, and small dense LDL.13,14 The increased propensity of persons with insulin resistance for cardiovascular events may be due to smaller arterial diameter (which is possibly due to increased diffuse atherosclerosis),15 impaired endothelial function,16,17 the propensity of insulin-resistant persons to develop hypertension,10 or an exaggerated inflammatory and proliferative response to injury.18–22 Nonetheless, the predisposing risk factors for, and the pathological characteristics of, coronary artery disease (CAD) in diabetic subjects are similar to those of the general population.23,24
Previous attempts to correlate glucose homeostasis with asymptomatic CAD have been limited by the inability to quantify preclinical coronary disease in asymptomatic persons. For practical purposes, stress tests are unable to detect nonobstructive coronary disease and although carotid artery intima-media thickness is associated with coronary disease,25–28 this association is relatively weak.29–32
Electron-beam computed tomography (CT)–derived coronary artery calcium (CAC) scores are closely correlated with total plaque burden,33–35 angiographic obstruction,36–39 and future cardiovascular events in symptomatic and asymptomatic persons.40–44 Furthermore, the relationships of CAC scores with the severity of coronary atherosclerosis and with the likelihood of future CAD events are independent of traditional CAD risk factors.38,42,43,45
Given the graded prognostic importance of coronary atherosclerosis,46 we performed metabolic testing and electron-beam CT on 1160 asymptomatic persons selected randomly from a population-based study. Our goals were to determine the relationship between insulin resistance, its associated metabolic abnormalities, and coronary calcification and, to the extent possible, to shed light on the cause(s) of insulin resistance.
|
Methods |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
The St. Francis Heart Study is a population-based natural history and randomized clinical trial of 50- to 70-year-old men and women with no clinical or historical evidence of CAD. The study is designed to explore new correlates of subclinical CAD by use of electron-beam CT and to test whether treatment with atorvastatin and antioxidants affects the likelihood of future cardiovascular events in men and women with elevated age- and sex-adjusted CAC scores. The present report describes the correlations of baseline CAC scores with CAD risk factors and insulin resistance parameters in a randomly selected subgroup of the St. Francis Heart Study.
The recruitment scheme for the St. Francis Heart Study is shown in Figure 1. Approximately 300 000 recruitment letters and questionnaires were sent to residents of Nassau and Queens counties in New York. Approximately one third of these were sent to every age-eligible subscriber of the Health Insurance Program of New York. The rest were sent to members of a variety of local organizations, such as the police department, YMCA, and chamber of commerce and to 
5000 local physicians. In addition, persons responded to advertising in a variety of local newspapers and local radio stations, including those targeted to an African American and Spanish audience, including the Anton Community Newspaper chain (24 newspapers with a readership of 60 000). Approximately 20 000 questionnaires were returned and screened for the exclusion criteria. Five thousand five hundred eighty-two subjects met the enrollment criteria (see below) and were invited for a screening coronary electron-beam CT.
|
One third of the subjects with CAC scores above the 80th percentile for age and sex and one fifth of the subjects with scores below the 80th percentile were randomly selected to participate in the risk factor analysis substudy. The choice of this particular cutoff point is based on the study of Raggi et al,43 in which subjects in the top 20th percentile of calcium scores had a risk ratio of 20 for future cardiovascular events, and the report by Rumberger et al39 on the sensitivity and specificity of various calcium score thresholds for obstructive disease in men and women of various ages.39 We believed that enrolling a higher percentage from the high-score group should result in a more useful range of observations by reducing the number of subjects with a zero score. The determination of age- and sex-adjusted percentile CAC scores was based on previous analysis of 5000 asymptomatic individuals who had previously undergone coronary screening at our institution, which is similar to the distribution of CAC scores in a cohort of 35 000 individuals scanned at the University of Illinois47 and in nearly 19 000 at the Cooper Clinic in Dallas.48
Patients were excluded from the study for any of the following conditions: (1) clinical evidence of atherosclerosis, including symptomatic coronary artery, cerebrovascular, or peripheral vascular disease, or other symptomatic heart disease; (2) diabetes mellitus requiring treatment with insulin; (3) any disease anticipated to cause death within 5 years; (4) bleeding diatheses; (5) cancer within the previous 5 years (except for skin cancer); (6) anemia requiring medical workup; (7) current systemic hormone therapy, including prescription estrogens or glucocorticoids; (8) current therapy with anticoagulants, cyclosporin, or lipid-lowering drugs or the intake of more than twice the required daily allowance of vitamin E (total >60 IU/d) or vitamin C (total >120 mg/d); (9) a coronary angiogram within the past 5 years; and (10) weight greater than the upper limit for the electron-beam CT scanner (300 lb).
Screening coronary electron-beam CT was performed by using an Imatron C-150XP scanner. Forty contiguous 3-mm-thick slices were obtained during a single breath-holding, beginning at the lower edge of the carina. The field of view was 35 cm, and the scan time was 100 ms per slice, with synchronized ECG triggering at 80% of the RR interval. CAC scores were calculated according to the method of Agatston et al.49 At least 2 adjacent pixels with a density >130 Hounsfield units were required to define a lesion.
In addition to coronary artery scanning, a single CT slice was obtained at the level of the umbilicus to assess intra-abdominal and subcutaneous fat distribution.50,51 The abdominal cavity was outlined on the computer screen, and the numbers of pixels appearing as fat (densities between -130 and 0 Hounsfield units) inside the abdominal cavity, as well as in the whole slice, were calculated. The amount of extra-abdominal (subcutaneous) fat was calculated by subtracting intra-abdominal fat from total abdominal fat. This method limits the radiation exposure, and the results are highly correlated with total abdominal fat.51 Abdominal height was determined as the distance between 2 parallel horizontal lines touching the most posterior and most anterior edges of the abdomen.
During the screening visit, we obtained a complete medical history and performed a comprehensive physical examination, including supine vital signs, standing height, weight, waist, and hip circumference, and triceps and subscapular skinfold thickness. A resting ECG was obtained. Patients with Q waves 
40 ms in 2 contiguous leads were excluded from the study. Those with Q waves 30 ms in 2 contiguous leads or poor R-wave progression underwent transthoracic echocardiography. Those with hypokinesis in areas corresponding to the ECG abnormalities were also excluded from the study.
During the same visit, we obtained fasting blood samples for the determination of lipid profile, including total cholesterol, triglycerides, HDL cholesterol, and calculated LDL cholesterol, a comprehensive chemistry profile, and a complete blood count. On a subsequent visit, the subjects underwent an oral glucose tolerance test. Serum concentrations of glucose and insulin were measured in the fasting state and again 2 hours after the oral administration of 75 g glucose.
Laboratory tests were performed on standard commercial instruments (LabCorp, Inc). Coefficients of variations for the lipids and chemistry assays were all <2%. Insulin was measured by a radioimmunoassay (Coat-A-Count) with interassay and intra-assay coefficient of variation of <10%.
Statistical Analyses
For analyses using discrete variables, insulin resistance markers were defined as follows: (1) HDL cholesterol concentration <35 mg/dL; (2) a history of hypertension, systolic blood pressure >140 mm Hg, or diastolic blood pressure >90 mg Hg; (3) intra-abdominal fat, abdominal height, or waist/hip ratio greater than the median for the 1160 subjects (120.9 cm2, 25.2 cm, and 0.9237, respectively); (4) a history of diabetes, fasting insulin, or 2-hour insulin greater than the median (11.6 and 54.1 µU/mL, respectively) or fasting serum glucose >126 mg/dL; and (5) fasting serum triglyceride concentration >200 mg/dL.
Insulin resistance without diabetes (or impaired glucose tolerance) is defined as serum glucose concentrations between 111 and 126 mg/dL.
Homeostasis model assessment (HOMA) insulin resistance is defined as follows: (FIxFG)22.5. The HOMA beta cell function is defined as follows: (20xFI)/(FG-3.5), where FI is fasting insulin, and FG is fasting glucose. These values correlate with measurements of insulin resistance and beta cell function by use of the euglycemic-hyperinsulinemic clamp and the hyperglycemic clamp, respectively.52
The associations between continuous baseline risk factors and CAC scores and among the CAD risk factors were assessed by use of Spearman correlations. Analyses were performed for the whole group, for men and women separately, for subjects with fasting serum glucose <126 mg/dL, and for subjects with fasting serum glucose <110 mg/dL.
Stepwise multivariate analyses of the correlation of various risk factors with the CAC scores were performed after logarithmic transformation of the calcium score and without forcing any variables into the models.
|
Results |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
Enrollment began in August 1996 and was completed in March 1999. One thousand one hundred sixty subjects were enrolled in the risk factor analysis substudy. More men than women volunteered and qualified for electron-beam CT screening (3479 men versus 2103 women) and for the risk factor analysis study (73.6% men versus 26.4% women). Percentages were as follows: 92.9% were white, 3.3% were African American, 1.8% were Hispanic, 1.3% were Asian, and 0.7% listed their race as "other." Mean age was 59±5.9 years. Mean CAC score was 169±348, with a range from 0 to 4057. Other baseline characteristics are shown in Table 1.
|
Table 2 shows the relationship between CAC scores and glucose, insulin, HOMA-derived insulin resistance, and HOMA-derived beta cell function. In the group as a whole, all parameters were positively and significantly associated with increased CAC, even in subjects with impaired glucose tolerance (fasting serum glucose 111 to 126 mg/dL) or normal fasting glucose. There were some differences between men and women. For example, fasting and 2-hour glucose levels were significantly correlated with calcium scores in women but not in men.
|
CAC scores increased progressively with an increasing number of insulin resistance markers (Figure 2, P for trend <0.0001).
|
CAC scores were positively correlated with fasting and postchallenge glucose and insulin concentrations, HOMA insulin resistance, and HOMA beta cell function (Table 2). Most of these correlations remained significant for men and women analyzed separately and for subjects with fasting serum glucose <126 mg/dL and those with fasting serum glucose <110 mg/dL. The correlations across these subgroups were most consistent for HOMA insulin resistance.
CAC scores were also correlated positively (in decreasing order) with waist/hip ratio, age, abdominal height, intra-abdominal fat, systolic blood pressure, triglycerides, diastolic blood pressure, LDL cholesterol concentration, and subscapular skinfold thickness. CAC scores were inversely correlated with HDL concentration and with triceps skinfold thickness and were not correlated with subcutaneous (extra-abdominal) fat (Table 3) There were some differences between men and women. For example, triglycerides, LDL, fasting and stimulated glucose and insulin, and subscapular skinfold thickness were significantly correlated with CAC scores in women, but only fasting insulin was correlated with CAC scores in men. Most of these correlations again remained significant for subjects with fasting serum glucose <126 mg/dL or <110 mg/dL.
|
As expected, many features of the insulin resistance syndrome were correlated with each other. The 3 measures of central/visceral adiposity were positively correlated with one another (r=0.42 to 0.82, P<0.0001). Visceral obesity was positively correlated with fasting and 2-hour glucose and insulin, systolic and diastolic blood pressures, and triglycerides and was inversely correlated with HDL (r=0.22 to 0.50, P<0.0001 for all parameters). There was no correlation between central obesity and LDL cholesterol. Subcutaneous fat was correlated with triceps skinfold thickness (both measures of peripheral fat accumulation). Fasting and stimulated insulin and glucose were correlated positively with triglycerides and systolic and diastolic blood pressures and negatively with HDL cholesterol (r=0.15 to 0.37, P<0.0001 for all parameters).
Multivariate Analyses
The final multivariate model included (in decreasing order) age, sex, a family history of premature atherosclerosis, LDL cholesterol, central obesity, and smoking (Table 4). The inclusion of any measure of central obesity, while excluding the other 2, resulted in a similar final model. All together, these 6 factors accounted for 82% of the overall variability in CAC scores (Figure 3). These correlations remained significant for subjects with fasting serum glucose <126 mg/dL and for subjects with fasting serum glucose <110 mg/dL. After adjustment for these 6 variables, HDL, triglycerides, glucose and insulin levels, HOMA insulin resistance and beta cell function, triceps skinfold thickness, and subcutaneous fat were no longer correlated with CAC scores in the multivariate model.
|
|
|
Discussion |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
The present study extends previous observations regarding the relationship of impaired glucose tolerance and insulin resistance with atherosclerosis. Using coronary electron-beam CT, we demonstrate for the first time that insulin resistance and its associated metabolic abnormalities are correlated with increased coronary atherosclerosis even in asymptomatic persons and even in the absence of elevated fasting serum glucose concentrations. Furthermore, HOMA beta cell function was positively correlated with CAC scores, indicating that asymptomatic CAD may be correlated with increased, rather than decreased, beta cell function.
Additionally, we found that intra-abdominal obesity was correlated with insulin resistance and with its associated metabolic characteristics. Furthermore, intra-abdominal obesity was the only parameter of the insulin resistance syndrome (including glucose, insulin, and HOMA insulin resistance) that remained independently correlated with CAC scores after the multivariate analysis.
These observations suggest that intra-abdominal adiposity but not peripheral adiposity is a significant contributor to insulin resistance and asymptomatic atherosclerosis. This interpretation of our data is consistent with epidemiological data correlating the increased incidence of insulin resistance and diabetes in western societies with increased obesity and with the effects of insulin sensitizers such as troglitazone to decrease intra-abdominal fat.53,54 It is also consistent with the observation by Barzilai and colleagues55,56 that surgical removal of intra-abdominal fat in Sprague-Dawley rats reverses hepatic insulin resistance.
Previous studies have reported that persons with diabetes but without evidence of CAD have a risk of future CAD events similar to persons with previous CAD but no diabetes57; these reports led to the suggestion that diabetics without symptoms of CAD should be treated according to secondary CAD prevention standards.58,59 Increased coronary calcification increases the risk of future cardiovascular events with odds ratios ranging from 8 to 25. The presence of increased coronary artery calcification in nondiabetic subjects with insulin resistance or high normal glucose suggest that such subjects might also benefit from reduction of LDL cholesterol to secondary prevention goals.
Other studies have documented a relationship between the presence of diabetes and coronary or peripheral calcification. Siitonen et al60 found increased aortic calcification in diabetic men by use of conventional chest radiography. Other investigators have reported a relationship between electron-beam CT–derived CAC scores and type II and type I diabetes.61–63 Yoshida et al64 found that increased coronary calcification was associated with increased likelihood of diabetic microvascular complications. In an autopsy study of sudden death cases, Burke et al65 found that coronary calcification was also associated with diabetes, as well as with an increased the likelihood of acute and healed plaque rupture. Finally, Mahoney et al66 found that markers of insulin resistance, such as increased body mass index, decreased HDL, and increased blood pressure in childhood, predict increased coronary calcification in young adults.
However, the present study is unique because of its large size, the unbiased selection of the study population, the careful exclusion of subjects with CAD, the direct assessment of insulin resistance and intra-abdominal adiposity, and the multivariate analyses. In addition, the exclusion of insulin-treated subjects and the separate analyses for nondiabetic subjects with milder degrees of insulin resistance should contribute to a more reliable determination of the relationship of endogenous hyperinsulinemia and CAD.
Study Limitations
It is possible that the recruitment scheme resulted in selection bias. However, we believe that our recruitment efforts were wide enough and reached a large enough population to make this unlikely. In particular, when every potential subject was approached, as in the case of Health Insurance Plan of NY patients, which constituted almost a third of the final population, no selection bias is possible. Naturally, our conclusions can be applied only to populations with similar demographics
It is possible that insulin resistance is implicated in the calcification process rather than in atherogenesis, per se. Although this possibility is difficult to exclude, plaque composition is similar in diabetic and nondiabetic persons,24 and CAC scores are well correlated with the severity of coronary atherosclerosis in pathological and angiographic studies, independent of traditional risk factors. Moreover, the increased incidence of CAD in diabetic patients67–69 is paralleled by the increase in coronary calcification.61,70 Therefore, we believe that the use of CAC scores as a measure of coronary atherosclerosis is justified.
Our conclusions are also limited by the inaccuracies inherent in the oral glucose challenge test compared with glucose clamp studies. However, it is not feasible to perform clamp studies on large populations, and HOMA model insulin resistance has been accepted as a surrogate measure for epidemiological studies.52
Finally, the correlation coefficients of the univariate analyses were relatively weak, although highly significant. We believe that this is the case because so many independent factors play a role in coronary calcification (and atherosclerosis itself) and that each must be relatively weak. In a multicausal disease such as atherosclerosis, one would expect each of many factors to have a relatively small contribution. Although age and sex explain a large part of the results, age and sex are also correlated with other risk factors, such as hypertension, increased cholesterol, and central obesity. In a multivariate analysis, these cross correlations will diminish the apparent contribution of associated risk factors. Similarly, male sex and aging are associated with increased insulin resistance, thus diluting the apparent contribution of insulin resistance in a multivariate analysis. Nonetheless, the data suggest that the presence of multiple risk factors, in particular, those associated with insulin resistance, is associated with increased risk of subclinical atherosclerosis.
We conclude that coronary atherosclerosis in asymptomatic individuals is correlated with insulin resistance and its associated metabolic abnormalities even in the absence of diabetes or impaired glucose intolerance. Additionally, intra-abdominal adiposity appears to be a major contributor to insulin resistance and increased atherosclerosis in such persons.
|
Acknowledgments |
|---|
This study was supported by a grant from the St. Francis Foundation.
Received August 16, 2001; accepted September 20, 2001.
|
References |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
1. Wagenknecht LE, D’Agostino RB, Haffner SM, Savage PJ, Rewers M. Impaired glucose tolerance, type 2 diabetes, and carotid wall thickness: the Insulin Resistance Atherosclerosis Study. Diabetes Care. 1998; 21: 1812–1818.[Abstract]
2. Chukwuma C, Tuomilehto J. Diabetes and the risk of stroke. J Diabetes Complications. 1993; 7: 250–262.[Medline] [Order article via Infotrieve]
3.
Agewall S, Fagerberg B, Attvall S, Wendelhag I, Urbanavicius V, Wikstrand J. Carotid artery wall intima-media thickness is associated with insulin-mediated glucose disposal in men at high and low coronary risk. Stroke. 1995; 26: 956–960.
4. Bonora E, Kiechl S, Oberhollenzer F, Egger G, Bonadonna RC, Muggeo M, Willeit J. Impaired glucose tolerance, type II diabetes mellitus and carotid atherosclerosis: prospective results from the Bruneck Study. Diabetologia. 2000; 43: 156–164.[Medline] [Order article via Infotrieve]
5. Fujimoto WY, Leonetti DL, Bergstrom RW, Shuman WP, Wahl PW. Cigarette smoking, adiposity, non-insulin-dependent diabetes, and coronary heart disease in Japanese-American men. Am J Med. 1990; 89: 761–771.[Medline] [Order article via Infotrieve]
6. Rodriguez BL, Lau N, Burchfiel CM, Abbott RD, Sharp DS, Yano K, Curb JD. Glucose intolerance and 23-year risk of coronary heart disease and total mortality: the Honolulu Heart Program. Diabetes Care. 1999; 22: 1262–1265.[Abstract]
7. Laakso M, Lehto S. Epidemiology of risk factors for cardiovascular disease in diabetes and impaired glucose tolerance. Atherosclerosis. 1998; 137 (suppl): S65–S73.[Medline] [Order article via Infotrieve]
8.
Pyorala M, Miettinen H, Laakso M, Pyorala K. Hyperinsulinemia predicts coronary heart disease risk in healthy middle-aged men: the 22-year follow-up results of the Helsinki Policemen Study. Circulation. 1998; 98: 398–404.
9.
Brooks B, Molyneaux L, Yue DK. Augmentation of central arterial pressure in type 1 diabetes. Diabetes Care. 1999; 22: 1722–1727.
10. Kashiwabara H, Inaba M, Maruno Y, Morita T, Awata T, Negishi K, Iitaka M, Katayama S. Insulin levels during fasting and the glucose tolerance test and Homa’s index predict subsequent development of hypertension. J Hypertens. 2000; 18: 83–88.[Medline] [Order article via Infotrieve]
11. Tayama K, Inukai T, Shimomura Y. Preperitoneal fat deposition estimated by ultrasonography in patients with non-insulin-dependent diabetes mellitus. Diabetes Res Clin Pract. 1999; 43: 49–58.[Medline] [Order article via Infotrieve]
12.
Fujimoto WY, Bergstrom RW, Boyko EJ, Chen KW, Leonetti DL, Newell-Morris L, Shofer JB, Wahl PW. Visceral adiposity and incident coronary heart disease in Japanese-American men: the 10-year follow-up results of the Seattle Japanese-American Community Diabetes Study. Diabetes Care. 1999; 22: 1808–1812.
13. Lehto S, Ronnemaa T, Pyorala K, Laakso M. Cardiovascular risk factors clustering with endogenous hyperinsulinaemia predict death from coronary heart disease in patients with type II diabetes. Diabetologia. 2000; 43: 148–155.[Medline] [Order article via Infotrieve]
14. Steiner G. Risk factors for macrovascular disease in type 2 diabetes: classic lipid abnormalities. Diabetes Care. 1999; 22 (suppl 3): C6–C9.[Medline] [Order article via Infotrieve]
15. Mosseri M, Nahir M, Rozenman Y, Lotan C, Admon D, Raz I, Gotsman MS. Diffuse narrowing of coronary arteries in diabetic patients: the earliest phase of coronary artery disease. Cardiology. 1998; 89: 103–110.[Medline] [Order article via Infotrieve]
16.
O’Driscoll G, Green D, Maiorana A, Stanton K, Colreavy F, Taylor R. Improvement in endothelial function by angiotensin-converting enzyme inhibition in non-insulin-dependent diabetes mellitus. J Am Coll Cardiol. 1999; 33: 1506–1511.
17.
Steinberg HO, Paradisi G, Cronin J, Crowde K, Hempfling A, Hook G, Baron AD. Type II diabetes abrogates sex differences in endothelial function in premenopausal women. Circulation. 2000; 101: 2040–2046.
18. Hsueh WA, Law RE. Cardiovascular risk continuum: implications of insulin resistance and diabetes. Am J Med. 1998; 105: 4S–14S.[Medline] [Order article via Infotrieve]
19. Rozenman Y, Sapoznikov D, Mosseri M, Gilon D, Lotan C, Nassar H, Weiss AT, Hasin Y, Gotsman MS. Long-term angiographic follow-up of coronary balloon angioplasty in patients with diabetes mellitus: a clue to the explanation of the results of the BARI study: Balloon Angioplasty Revascularization Investigation. J Am Coll Cardiol. 1997; 30: 1420–1425.[Abstract]
20.
Festa A, D’Agostino RJr, Howard G, Mykkanen L, Tracy RP, Haffner SM. Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS). Circulation. 2000; 102: 42–47.
21. Schmidt MI, Duncan BB, Sharrett AR, Lindberg G, Savage PJ, Offenbacher S, Azambuja MI, Tracy RP, Heiss G. Markers of inflammation and prediction of diabetes mellitus in adults (Atherosclerosis Risk in Communities study): a cohort study. Lancet. 1999; 353: 1649–1652.[Medline] [Order article via Infotrieve]
22. Jager A, van Hinsbergh VW, Kostense PJ, Emeis JJ, Nijpels G, Dekker JM, Heine RJ, Bouter LM, Stehouwer CD. Increased levels of soluble vascular cell adhesion molecule 1 are associated with risk of cardiovascular mortality in type 2 diabetes: the Hoorn study. Diabetes. 2000; 49: 485–491.[Abstract]
23.
Temelkova-Kurktschiev TS, Koehler C, Leonhardt W, Schaper F, Henkel E, Siegert G, Hanefeld M. Increased intimal-medial thickness in newly detected type 2 diabetes: risk factors. Diabetes Care. 1999; 22: 333–338.
24.
Vavuranakis M, Stefanadis C, Toutouzas K, Pitsavos C, Spanos V, Toutouzas P. Impaired compensatory coronary artery enlargement in atherosclerosis contributes to the development of coronary artery stenosis in diabetic patients: an in vivo intravascular ultrasound study. Eur Heart J. 1997; 18: 1090–1094.
25.
Hodis HN, Mack WJ, LaBree L, Selzer RH, Liu CR, Liu CH, Azen SP. The role of carotid arterial intima-media thickness in predicting clinical coronary events. Ann Intern Med. 1998; 128: 262–269.
26.
O’Leary DH, Polak JF, Kronmal RA, Manolio TA, Burke GL, Wolfson SK. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults: Cardiovascular Health Study Collaborative Research Group. N Engl J Med. 1999; 340: 14–22.
27.
Geroulakos G, O’Gorman DJ, Kalodiki E, Sheridan DJ, Nicolaides AN. The carotid intima-media thickness as a marker of the presence of severe symptomatic coronary artery disease. Eur Heart J. 1994; 15: 781–785.
28.
Kallikazaros I, Tsioufis C, Sideris S, Stefanadis C, Toutouzas P. Carotid artery disease as a marker for the presence of severe coronary artery disease in patients evaluated for chest pain. Stroke. 1999; 30: 1002–1007.
29.
Adams MR, Nakagomi A, Keech A, Robinson J, McCredie R, Bailey BP, Freedman SB, Celermajer DS. Carotid intima-media thickness is only weakly correlated with the extent and severity of coronary artery disease. Circulation. 1995; 92: 2127–2134.
30.
Chen WH, Ho DS, Ho SL, Cheung RT, Cheng SW. Prevalence of extracranial carotid and vertebral artery disease in Chinese patients with coronary artery disease. Stroke. 1998; 29: 631–634.
31. Mack WJ, LaBree L, Liu C, Selzer RH, Hodis HN. Correlations between measures of atherosclerosis change using carotid ultrasonography and coronary angiography. Atherosclerosis. 2000; 150: 371–379.[Medline] [Order article via Infotrieve]
32. Crouse JRIII. Carotid and coronary atherosclerosis: what are the connections? Postgrad Med. 1991; 90: 175–179.[Medline] [Order article via Infotrieve]
33.
Mautner GC, Mautner SL, Froehlich J, Feuerstein IM, Proschan MA, Roberts WC, Doppman JL. Coronary artery calcification: assessment with electron beam CT and histomorphometric correlation. Radiology. 1994; 192: 619–623.
34.
Rumberger JA, Simons DB, Fitzpatrick LA, Sheedy PF, Schwartz RS. Coronary artery calcium area by electron-beam computed tomography and coronary atherosclerotic plaque area: a histopathologic correlative study. Circulation. 1995; 92: 2157–2162.
35.
Sangiorgi G, Rumberger JA, Severson A, Edwards WD, Gregoire J, Fitzpatrick LA, Schwartz RS. Arterial calcification and not lumen stenosis is highly correlated with atherosclerotic plaque burden in humans: a histologic study of 723 coronary artery segments using nondecalcifying methodology. J Am Coll Cardiol. 1998; 31: 126–133.
36.
Budoff MJ, Georgiou D, Brody A, Agatston AS, Kennedy J, Wolfkiel C, Stanford W, Shields P, Lewis RJ, Janowitz WR, et al. Ultrafast computed tomography as a diagnostic modality in the detection of coronary artery disease: a multicenter study. Circulation. 1996; 93: 898–904.
37. Guerci AD, Spadaro LA, Popma JJ, Goodman KJ, Brundage BH, Budoff M, Lerner G, Vizza RF. Relation of coronary calcium score by electron beam computed tomography to arteriographic findings in asymptomatic and symptomatic adults. Am J Cardiol. 1997; 79: 128–133.[Medline] [Order article via Infotrieve]
38.
Guerci AD, Spadaro LA, Goodman KJ, Lledo-Perez A, Newstein D, Lerner G, Arad Y. Comparison of electron beam computed tomography scanning and conventional risk factor assessment for the prediction of angiographic coronary artery disease. J Am Coll Cardiol. 1998; 32: 673–679.
39. Rumberger JA, Sheedy PF, Breen JF, Schwartz RS. Electron beam computed tomographic coronary calcium score cutpoints and severity of associated angiographic lumen stenosis. J Am Coll Cardiol. 1997; 29: 1542–1548.[Abstract]
40. Detrano R, Hsiai T, Wang S, Puentes G, Fallavollita J, Shields P, Stanford W, Wolfkiel C, Georgiou D, Budoff M, et al. Prognostic value of coronary calcification and angiographic stenoses in patients undergoing coronary angiography. J Am Coll Cardiol. 1996; 27: 285–290.[Abstract]
41. O’Malley PG, Taylor AJ, Jackson JL, Doherty TM, Detrano RC. Prognostic value of coronary electron-beam computed tomography for coronary heart disease events in asymptomatic populations. Am J Cardiol. 2000; 85: 945–948.[Medline] [Order article via Infotrieve]
42. Wong ND, Hsu JC, Detrano RC, Diamond G, Eisenberg H, Gardin JM. Coronary artery calcium evaluation by electron beam computed tomography and its relation to new cardiovascular events. Am J Cardiol. 2000; 86: 495–498.[Medline] [Order article via Infotrieve]
43.
Raggi P, Callister TQ, Cooil B, He ZX, Lippolis NJ, Russo DJ, Zelinger A, Mahmarian JJ. Identification of patients at increased risk of first unheralded acute myocardial infarction by electron-beam computed tomography. Circulation. 2000; 101: 850–855.
44.
Arad Y, Spadaro LA, Goodman K, Newstein D, Guerci AD. Prediction of coronary events with electron beam computed tomography. J Am Coll Cardiol. 2000; 36: 1253–1260.
45.
Schmermund A, Baumgart D, Gorge G, Gronemeyer D, Seibel R, Bailey KR, Rumberger JA, Paar D, Erbel R. Measuring the effect of risk factors on coronary atherosclerosis: coronary calcium score versus angiographic disease severity [published erratum appears in J Am Coll Cardiol. 1998;32:555]. J Am Coll Cardiol. 1998; 31: 1267–1273.
46. Gofman JW. The quantitative nature of the relationship of coronary artery atherosclerosis and coronary heart disease risk. Cardiol Digest. 1969; 4: 28–38.
47. Hoff JA, Chomka EV, Krainik AJ, Daviglus M, Rich S, Kondos GT. Age and gender distributions of coronary artery calcium detected by electron beam tomography in 35,246 adults. Am J Cardiol. 2001; 87: 1335–1339.[Medline] [Order article via Infotrieve]
48. Mitchell TL, Pippin JJ, Devers SM, Kimball TE, Cannaday JJ, Gibbons LW, Cooper KH. Age- and sex-based nomograms from coronary artery calcium scores as determined by electron beam computed tomography. Am J Cardiol. 2001; 87: 453–456.[Medline] [Order article via Infotrieve]
49. Agatston AS, Janowitz WR, Hildner FJ, Zusmer NR, Viamonte M, Detrano R. Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol. 1990; 15: 827–832.[Abstract]
50. Gower BA, Nagy TR, Goran MI. Visceral fat, insulin sensitivity, and lipids in prepubertal children. Diabetes. 1999; 48: 1515–1521.[Abstract]
51. Matsuura F, Yamashita S, Nakamura T, Nishida M, Nozaki S, Funahashi T, Matsuzawa Y. Effect of visceral fat accumulation on uric acid metabolism in male obese subjects: visceral fat obesity is linked more closely to overproduction of uric acid than subcutaneous fat obesity. Metabolism. 1998; 47: 929–933.[Medline] [Order article via Infotrieve]
52. Haffner SM, Kennedy E, Gonzalez C, Stern MP, Miettinen H. A prospective analysis of the HOMA model: the Mexico City Diabetes Study. Diabetes Care. 1996; 19: 1138–1141.[Abstract]
53. Mori Y, Murakawa Y, Okada K, Horikoshi H, Yokoyama J, Tajima N, Ikeda Y. Effect of troglitazone on body fat distribution in type 2 diabetic patients. Diabetes Care. 1999; 22: 908–912.[Abstract]
54.
Kelly IE, Han TS, Walsh K, Lean ME. Effects of a thiazolidinedione compound on body fat and fat distribution of patients with type 2 diabetes [published erratum appears in Diabetes Care. 1999;22:536]. Diabetes Care. 1999; 22: 288–293.
55. Barzilai N, She L, Liu L, Wang J, Hu M, Vuguin P, Rossetti L. Decreased visceral adiposity accounts for leptin effect on hepatic but not peripheral insulin action. Am J Physiol. 1999; 277: E291–E298.[Medline] [Order article via Infotrieve]
56. Barzilai N, She L, Liu BQ, Vuguin P, Cohen P, Wang J, Rossetti L. Surgical removal of visceral fat reverses hepatic insulin resistance. Diabetes. 1999; 48: 94–98.[Abstract]
57.
Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med. 1998; 339: 229–234.
58. Haffner SM. Patients with type 2 diabetes: the case for primary prevention. Am J Med. 1999; 107: 43S–45S.[Medline] [Order article via Infotrieve]
59.
Grover SA, Coupal L, Zowall H, Dorais M. Cost-effectiveness of treating hyperlipidemia in the presence of diabetes: who should be treated? Circulation. 2000; 102: 722–727.
60. Siitonen O, Uusitupa M, Pyorala K, Lansimies E, Voutilainen E. Aortic calcifications and their relationship to coronary heart disease and cardiovascular risk factors in patients with newly diagnosed non-insulin-dependent diabetes and in nondiabetic subjects. Cardiology. 1987; 74: 335–343.[Medline] [Order article via Infotrieve]
61. Wong ND, Kouwabunpat D, Vo AN, Detrano RC, Eisenberg H, Goel M, Tobis JM. Coronary calcium and atherosclerosis by ultrafast computed tomography in asymptomatic men and women: relation to age and risk factors. Am Heart J. 1994; 127: 422–430.[Medline] [Order article via Infotrieve]
62.
Simon A, Giral P, Levenson J. Extracoronary atherosclerotic plaque at multiple sites and total coronary calcification deposit in asymptomatic men: association with coronary risk profile. Circulation. 1995; 92: 1414–1421.
63. Olson JC, Edmundowicz D, Becker DJ, Kuller LH, Orchard TJ. Coronary calcium in adults with type 1 diabetes: a stronger correlate of clinical coronary artery disease in men than in women. Diabetes. 2000; 49: 1571–1578.[Abstract]
64. Yoshida M, Takamatsu J, Yoshida S, Tanaka K, Takeda K, Higashi H, Kitaoka H, Ohsawa N. Scores of coronary calcification determined by electron beam computed tomography are closely related to the extent of diabetes-specific complications. Horm Metab Res. 1999; 31: 558–563.[Medline] [Order article via Infotrieve]
65. Burke AP, Taylor A, Farb A, Malcom GT, Virmani R. Coronary calcification: insights from sudden coronary death victims. Z Kardiol. 2000; 89: 49–53.[Medline] [Order article via Infotrieve]
66. Mahoney LT, Burns TL, Stanford W, Thompson BH, Witt JD, Rost CA, Lauer RM. Coronary risk factors measured in childhood and young adult life are associated with coronary artery calcification in young adults: the Muscatine Study. J Am Coll Cardiol. 1996; 27: 277–284.[Abstract]
67. Pyorala K. Diabetes and coronary artery disease: what a coincidence? J Cardiovasc Pharmacol. 1990; 16: S8–S14.
68. Aronow WS, Ahn C. Association of diabetes mellitus using old and new diagnostic criteria with incidence of new coronary events in older men and women. Am J Cardiol. 2000; 85: 104–105.[Medline] [Order article via Infotrieve]
69. Gillum RF, Mussolino ME, Madans JH. Diabetes mellitus, coronary heart disease incidence, and death from all causes in African American and European American women: the NHANES I epidemiologic follow-up study. J Clin Epidemiol. 2000; 53: 511–518.[Medline] [Order article via Infotrieve]
70. Khaleeli E, Peters SR, Bobrowsky K, Oudiz RJ, Ko JY, Budoff MJ. Diabetes and the associated incidence of subclinical atherosclerosis and coronary artery disease: implications for management. Am Heart J. 2001; 141: 637–644.[Medline] [Order article via Infotrieve]
This article has been cited by other articles:
 |
|
 |
|
  R. Katz, M. J. Budoff, J. Takasu, D. M. Shavelle, A. Bertoni, R. S. Blumenthal, P. Ouyang, N. D. Wong, and K. D. O'Brien Relationship of Metabolic Syndrome With Incident Aortic Valve Calcium and Aortic Valve Calcium Progression: The Multi-Ethnic Study of Atherosclerosis (MESA) Diabetes, April 1, 2009; 58(4): 813 - 819. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Kobayashi, M. Oka, K. Maesato, R. Ikee, T. Mano, M. Hidekazu, and T. Ohtake Coronary Artery Calcification, ADMA, and Insulin Resistance in CKD Patients Clin. J. Am. Soc. Nephrol., September 1, 2008; 3(5): 1289 - 1295. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. D. Reaven, N. Emanuele, T. Moritz, R. Klein, M. Davis, K. Glander, W. Duckworth, C. Abraira, and for the Veterans Affairs Diabetes Trial (VADT) Proliferative Diabetic Retinopathy in Type 2 Diabetes Is Related to Coronary Artery Calcium in the Veterans Affairs Diabetes Trial (VADT) Diabetes Care, May 1, 2008; 31(5): 952 - 957. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. A. Lear, K. H. Humphries, S. Kohli, J. J. Frohlich, C. L. Birmingham, and G. B. J. Mancini Visceral Adipose Tissue, a Potential Risk Factor for Carotid Atherosclerosis: Results of the Multicultural Community Health Assessment Trial (M-CHAT) Stroke, September 1, 2007; 38(9): 2422 - 2429. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C.-D. Lee, D. R Jacobs Jr, P. J Schreiner, C. Iribarren, and A. Hankinson Abdominal obesity and coronary artery calcification in young adults: the Coronary Artery Risk Development in Young Adults (CARDIA) Study Am. J. Clinical Nutrition, July 1, 2007; 86(1): 48 - 54. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Nisoli, E. Clementi, M. O. Carruba, and S. Moncada Defective Mitochondrial Biogenesis: A Hallmark of the High Cardiovascular Risk in the Metabolic Syndrome? Circ. Res., March 30, 2007; 100(6): 795 - 806. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Mazzone, P. M. Meyer, G. T. Kondos, M. H. Davidson, S. B. Feinstein, R. B. D'Agostino Sr., A. Perez, and S. M. Haffner Relationship of Traditional and Nontraditional Cardiovascular Risk Factors to Coronary Artery Calcium in Type 2 Diabetes Diabetes, March 1, 2007; 56(3): 849 - 855. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. A. M. den Boer, P. J. Voshol, J. P. Schroder-van der Elst, E. Korsheninnikova, D. M. Ouwens, F. Kuipers, L. M. Havekes, and J. A. Romijn Endogenous Interleukin-10 Protects against Hepatic Steatosis but Does Not Improve Insulin Sensitivity during High-Fat Feeding in Mice Endocrinology, October 1, 2006; 147(10): 4553 - 4558. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Katz, N. D. Wong, R. Kronmal, J. Takasu, D. M. Shavelle, J. L. Probstfield, A. G. Bertoni, M. J. Budoff, and K. D. O'Brien Features of the Metabolic Syndrome and Diabetes Mellitus as Predictors of Aortic Valve Calcification in the Multi-Ethnic Study of Atherosclerosis Circulation, May 2, 2006; 113(17): 2113 - 2119. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. P. Burdon, J. L. Bento, C. D. Langefeld, J. K. Campbell, J. J. Carr, L. M. Wagenknecht, D. M. Herrington, B. I. Freedman, S. S. Rich, and D. W. Bowden Association of Protein Tyrosine Phosphatase-N1 Polymorphisms With Coronary Calcified Plaque in the Diabetes Heart Study Diabetes, March 1, 2006; 55(3): 651 - 658. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. T. Bloomgarden Inflammation, Atherosclerosis, and Aspects of Insulin Action Diabetes Care, September 1, 2005; 28(9): 2312 - 2319. [Full Text] [PDF]
|
|
|
|
 |
|
 P. K. Agatisa, K. A. Matthews, J. T. Bromberger, D. Edmundowicz, Y.-F. Chang, and K. Sutton-Tyrrell Coronary and Aortic Calcification in Women With a History of Major Depression Arch Intern Med, June 13, 2005; 165(11): 1229 - 1236. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. O. Talbott, J. V. Zborowski, J. R. Rager, M. Y. Boudreaux, D. A. Edmundowicz, and D. S. Guzick Evidence for an Association between Metabolic Cardiovascular Syndrome and Coronary and Aortic Calcification among Women with Polycystic Ovary Syndrome J. Clin. Endocrinol. Metab., November 1, 2004; 89(11): 5454 - 5461. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. P. Reilly, M. L. Wolfe, T. Rhodes, C. Girman, N. Mehta, and D. J. Rader Measures of Insulin Resistance Add Incremental Value to the Clinical Diagnosis of Metabolic Syndrome in Association With Coronary Atherosclerosis Circulation, August 17, 2004; 110(7): 803 - 809. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. B. Carr, K. M. Utzschneider, R. L. Hull, K. Kodama, B. M. Retzlaff, J. D. Brunzell, J. B. Shofer, B. E. Fish, R. H. Knopp, and S. E. Kahn Intra-Abdominal Fat Is a Major Determinant of the National Cholesterol Education Program Adult Treatment Panel III Criteria for the Metabolic Syndrome Diabetes, August 1, 2004; 53(8): 2087 - 2094. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K P Morgan, A Kapur, and K J Beatt Anatomy of coronary disease in diabetic patients: an explanation for poorer outcomes after percutaneous coronary intervention and potential target for intervention Heart, July 1, 2004; 90(7): 732 - 738. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Raggi, L. J. Shaw, D. S. Berman, and T. Q. Callister Prognostic value of coronary artery calcium screening in subjects with and without diabetes J. Am. Coll. Cardiol., May 5, 2004; 43(9): 1663 - 1669. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. den Boer, P.J. Voshol, F. Kuipers, L.M. Havekes, and J.A. Romijn Hepatic Steatosis: A Mediator of the Metabolic Syndrome. Lessons From Animal Models Arterioscler Thromb Vasc Biol, April 1, 2004; 24(4): 644 - 649. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. J. Woodhouse, N. Gupta, M. Bhasin, A. B. Singh, R. Ross, J. Phillips, and S. Bhasin Dose-Dependent Effects of Testosterone on Regional Adipose Tissue Distribution in Healthy Young Men J. Clin. Endocrinol. Metab., February 1, 2004; 89(2): 718 - 726. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H.-H. S. Oei, R. Vliegenthart, A. Hofman, M. Oudkerk, and J. C.M. Witteman Risk factors for coronary calcification in older subjects: The Rotterdam Coronary Calcification Study Eur. Heart J., January 1, 2004; 25(1): 48 - 55. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. A Henriksen, K A. Lockman, S. J Robertson, D. Clark, J. I. Barclay, J. Chalmers, and I. W Campbell Audit of cardiovascular risk assessment in type 2 diabetic patients referred for insulin therapy: a cardiological perspective The British Journal of Diabetes & Vascular Disease, January 1, 2004; 4(1): 34 - 38. [Abstract] [PDF]
|
|
|
|
|
|
D. Dabelea, G. Kinney, J. K. Snell-Bergeon, J. E. Hokanson, R. H. Eckel, J. Ehrlich, S. Garg, R. F. Hamman, and M. Rewers Effect of Type 1 Diabetes on the Gender Difference in Coronary Artery Calcification: a Role for Insulin Resistance?: The Coronary Artery Calcification in Type 1 Diabetes (CACTI) Study Diabetes, November 1, 2003; 52(11): 2833 - 2839. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. K. Snell-Bergeon, J. E. Hokanson, L. Jensen, T. MacKenzie, G. Kinney, D. Dabelea, R. H. Eckel, J. Ehrlich, S. Garg, and M. Rewers Progression of Coronary Artery Calcification in Type 1 Diabetes: The importance of glycemic control Diabetes Care, October 1, 2003; 26(10): 2923 - 2928. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. P. Reilly, M. L. Wolfe, A. R. Localio, and D. J. Rader C-Reactive Protein and Coronary Artery Calcification: The Study of Inherited Risk of Coronary Atherosclerosis (SIRCA) Arterioscler Thromb Vasc Biol, October 1, 2003; 23(10): 1851 - 1856. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. B. Tanko, Y. Z. Bagger, P. Alexandersen, P. J. Larsen, and C. Christiansen Peripheral Adiposity Exhibits an Independent Dominant Antiatherogenic Effect in Elderly Women Circulation, April 1, 2003; 107(12): 1626 - 1631. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Freemark Pharmacologic Approaches to the Prevention of Type 2 Diabetes in High Risk Pediatric Patients J. Clin. Endocrinol. Metab., January 1, 2003; 88(1): 3 - 13. [Full Text] [PDF]
|
|
|
|
 |
|
 K. J. Stewart Exercise Training and the Cardiovascular Consequences of Type 2 Diabetes and Hypertension: Plausible Mechanisms for Improving Cardiovascular Health JAMA, October 2, 2002; 288(13): 1622 - 1631. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. L Demer Vascular calcification and osteoporosis: inflammatory responses to oxidized lipids Int. J. Epidemiol., August 1, 2002; 31(4): 737 - 741. [Full Text] [PDF]
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||